The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Open accessAbstract
Little is known about the biochemical environment in phagosomes harboring an infectious agent. To assess the state of this organelle we captured the transcriptional responses of Mycobacterium tuberculosis (MTB) in macrophages from wild-type and nitric oxide (NO) synthase 2–deficient mice before and after immunologic activation. The intraphagosomal transcriptome was compared with the transcriptome of MTB in standard broth culture and during growth in diverse conditions designed to simulate features of the phagosomal environment. Genes expressed differentially as a consequence of intraphagosomal residence included an interferon γ– and NO-induced response that intensifies an iron-scavenging program, converts the microbe from aerobic to anaerobic respiration, and induces a dormancy regulon. Induction of genes involved in the activation and β-oxidation of fatty acids indicated that fatty acids furnish carbon and energy. Induction of σE-dependent, sodium dodecyl sulfate–regulated genes and genes involved in mycolic acid modification pointed to damage and repair of the cell envelope. Sentinel genes within the intraphagosomal transcriptome were induced similarly by MTB in the lungs of mice. The microbial transcriptome thus served as a bioprobe of the MTB phagosomal environment, showing it to be nitrosative, oxidative, functionally hypoxic, carbohydrate poor, and capable of perturbing the pathogen's cell envelope.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have reported that nuo is down-regulated in M. tuberculosis during mouse lung infection (18), survival in macrophages (19), in both non-replicating persistence (NRP)-1 (1% oxygen saturation) and NRP-2 (0.06% oxygen saturation) relative to aerated mid-log growth (18), and upon starvation in vitro (20).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, fumarate reductase, nitrate reductase and NDH-2 are all upregulated under these conditions (19).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Transcriptional analysis of M. tuberculosis in the macrophage (phagosomal environment) has revealed that NDH-1, menaquinol-cytochrome c oxidoreductase and the ATP synthase are all down-regulated when compared to cells growing exponentially, suggesting that there is a reduced need for energy generation during bacteriostasis i.e., the growth state of intraphagosomal M. tuberculosis (19).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“In M. tuberculosis, the atp operon is downregulated during growth in macrophages (19), the mouse lung and in cells exposed to NO or hypoxia (18).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [19]
In the citing paper
“the fight of the host against the pathogen in M. tuberculosis infection involves several levels including containment of the microbe, generation of radicals and a hostile, acidic environment, deprivation from essential nutrients, formation of anti-mycobacterial peptides and cytokines which strengthen host responses by attracting other immune cells, down to cell damage and suicidal activities of MO”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [5]
In the citing paper
“Accordingly, transcriptional analysis of macrophages and M. tuberculosis has demonstrated that Mycobacteria regulate a myriad of genes to secure a sufficient supply of iron within the cell, whereas macrophages aim to restrict the availability of this metal by different mechanisms (5).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Escherichia coli and Salmonella.
Neidhart, F. C. (1996) · Cited by 1,577
Common themes in microbial pathogenicity revisited
Finlay, B. B., & Falkow, S. (1997) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.61.2.136-169.1997 · Cited by 1,474
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469
Self-citationBetts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
McKinney, J. D., zu Bentrup, K. H., Muñoz‐Elías, E. J., Miczák, A., Chen, B., Chan, W.-T., Swenson, D. L., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,361
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Flagged first, then by citations
Research works printed but not linked: 1
- 1997, Microbiol. Mol. Biol. Rev., 61, 136
Cited by
Sorted by citations
Items 101–200 of 1,000
Hampshire, T., Soneji, S., Bacon, J., James, B. W., Hinds, J., Laing, K. G., Stabler, R. A., Marsh, P. D., & Butcher, P. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.12.010 · Cited by 215
Self-citationLeptospirosis: pathogenesis, immunity, and diagnosis
Palaniappan, R. U. M., Ramanujam, S., & Chang, Y. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32814a5729 · Cited by 212
Kendall, S. L., Withers, M., Soffair, C. N., Moreland, N. J., Gurcha, S. S., Sidders, B. S., Frita, R., ten Bokum, A., Besra, G. S., Lott, J. S., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05827.x · Cited by 212
Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling
Jain, M., Petzold, C. J., Schelle, M. W., Leavell, M. D., Mougous, J. D., Bertozzi, C. R., Leary, J. A., & Cox, J. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610634104 · Cited by 211
Liu, Y., Tan, S., Huang, L., Abramovitch, R. B., Rohde, K. H., Zimmerman, M. D., Chen, C., Dartois, V. A., VanderVen, B. C., & Russell, D. G. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151248 · Cited by 206
Self-citationRegulators of bacterial responses to nitric oxide
Spiro, S. (2007) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00061.x · Cited by 208
Kalscheuer, R., Weinrick, B. C., Usha, V., Besra, G. S., & Jacobs, W. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014642108 · Cited by 209
A Comparative Lipidomics Platform for Chemotaxonomic Analysis of Mycobacterium tuberculosis
Layre, E., Sweet, L., Hong, S., Madigan, C. A., Desjardins, D., Young, D. C., Cheng, T., Annand, J. W., Kim, K., Shamputa, I. C., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.10.013 · Cited by 205
Cook, G. M., Berney, M., Gebhard, S., Heinemann, M., Cox, R. A., Danilchanka, O., & Niederweis, M. (2009) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(09)05502-7 · Cited by 226
Sierra‐Filardi, E., Vega, M. A., Sánchez‐Mateos, P., Corbí, A. L., & Puig‐Kröger, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.020 · Cited by 209
Secreted transcription factor controls Mycobacterium tuberculosis virulence
Raghavan, S., Manzanillo, P., Chan, K., Dovey, C., & Cox, J. S. (2008) · Nature · doi:10.1038/nature07219 · Cited by 202
Mycobacterial Mutants with Defective Control of Phagosomal Acidification
Stewart, G. R., Patel, J., Robertson, B. D., Rae, A. J., & Young, D. B. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010033 · Cited by 198
Tian, J., Bryk, R., Itoh, M., Suematsu, M., & Nathan, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501605102 · Cited by 200
Self-citationHuman macrophage host defense against Mycobacterium tuberculosis
Liu, P. T., & Modlin, R. L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.014 · Cited by 202
Geiman, D., Raghunand, T. R., Agarwal, N., & Bishai, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-06 · Cited by 204
Mycobacterium tuberculosis Wears What It Eats
Russell, D. G., VanderVen, B. C., Lee, W., Abramovitch, R. B., Kim, M., Homolka, S., Niemann, S., & Rohde, K. H. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.002 · Cited by 198
Tailleux, L., Waddell, S. J., Pelizzola, M., Mortellaro, A., Withers, M., Tanne, A. J., Castagnoli, P. R., Gicquel, B., Stoker, N. G., Butcher, P. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001403 · Cited by 206
Self-citationCtpV: a putative copper exporter required for full virulence of Mycobacterium tuberculosis
Ward, S. K., Abomoelak, B., Hoye, E. A., Steinberg, H. N., & Talaat, A. M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07273.x · Cited by 198
Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis
Ouellet, H., Johnston, J. B., & de Montellano, P. R. O. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.07.009 · Cited by 196
Targeting Bacterial Central Metabolism for Drug Development
Murima, P., McKinney, J. D., & Pethe, K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.020 · Cited by 194
Kahnert, A., Seiler, P. J., Stein, M., Bandermann, S., Hahnke, K., Mollenkopf, H., & Kaufmann, S. H. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200535496 · Cited by 190
Identification of small RNAs in Mycobacterium tuberculosis
Arnvig, K. B., & Young, D. B. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06777.x · Cited by 182
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Petruccioli, E., Scriba, T. J., Petrone, L., Hatherill, M., Cirillo, D. M., Joosten, S. A., Ottenhoff, T. H. M., Denkinger, C. M., & Goletti, D. (2016) · European Respiratory Journal · doi:10.1183/13993003.01012-2016 · Cited by 187
Division and Cell Envelope Regulation by Ser/Thr Phosphorylation:MycobacteriumShows the Way
Molle, V., & Kremer, L. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07041.x · Cited by 198
Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis
Vilchèze, C., Hartman, T. E., Weinrick, B. C., Jain, P., Weisbrod, T. R., Leung, L. W., Freundlich, J. S., & Jacobs, W. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704376114 · Cited by 185
Selective Killing of Nonreplicating Mycobacteria
Bryk, R., Gold, B., Venugopal, A., Singh, J., Samy, R. D., Pupek, K., Cao, H., Popescu, C., Gurney, M., Hotha, S., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.003 · Cited by 183
Self-citationRv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis
Nazarova, E. V., Montague, C. R., La, T., Wilburn, K. M., Sukumar, N., Lee, W., Caldwell, S., Russell, D. G., & VanderVen, B. C. (2017) · eLife · doi:10.7554/elife.26969 · Cited by 183
The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug TargetsPreprint
Mdluli, K. E., Kaneko, T., & Upton, A. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021154 · Cited by 185
Bretl, D. J., Demetriadou, C., & Zahrt, T. C. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05004-11 · Cited by 182
Global Transcriptional Profile of Mycobacterium tuberculosis during THP-1 Human Macrophage Infection
Fontán, P. A., Aris, V. M., Ghanny, S., Soteropoulos, P., & Smith, I. (2007) · Infection and Immunity · doi:10.1128/iai.00974-07 · Cited by 180
Balganesh, M., Dinesh, N., Sharma, S., Kuruppath, S., Nair, A. V., & Sharma, U. K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06003-11 · Cited by 176
Stress Wars: the Direct Role of Host and Bacterial Molecular Chaperones in Bacterial Infection
Henderson, B. E., Allan, E., & Coates, A. R. M. (2006) · Infection and Immunity · doi:10.1128/iai.01882-05 · Cited by 176
The sigma factors of Mycobacterium tuberculosis : regulation of the regulators
Sachdeva, P., Misra, R., Tyagi, A. K., & Singh, Y. P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07479.x · Cited by 174
Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 Steroids
Capyk, J. K., Kalscheuer, R., Stewart, G. R., Liu, J., Kwon, H., Zhao, R., Okamoto, S., Jacobs, W. R., Eltis, L. D., & Mohn, W. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072132 · Cited by 174
Thiol-based redox switches in prokaryotes
Hillion, M., & Antelmann, H. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0102 · Cited by 173
Biphasic Dynamics of Macrophage Immunometabolism during Mycobacterium tuberculosis Infection
Shi, L., Jiang, Q., Bushkin, Y., Subbian, S., & Tyagi, S. (2019) · mBio · doi:10.1128/mbio.02550-18 · Cited by 173
Wehrly, T. D., Chong, A., Virtaneva, K. I., Sturdevant, D. E., Child, R., Edwards, J. A., Brouwer, D., Nair, V., Fischer, E. R., Wicke, L., et al. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01316.x · Cited by 171
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
Gupta, S., Tyagi, S. K., Almeida, D. V., Maiga, M. C., Ammerman, N. C., & Bishai, W. R. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0650oc · Cited by 168
Mycobacterium tuberculosis Is Able To Accumulate and Utilize Cholesterol
Brzostek, A. M., Pawełczyk, J., Rumijowska-Galewicz, A., Dziadek, B. R., & Dziadek, J. (2009) · Journal of Bacteriology · doi:10.1128/jb.00488-09 · Cited by 171
Dorhoi, A., Reece, S. T., & Kaufmann, S. H. E. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00994.x · Cited by 172
Interaction of pathogenic mycobacteria with the host immune system
Houben, E. N. G., Nguyen, L., & Pieters, J. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.12.014 · Cited by 172
Rhee, K. Y., Erdjument‐Bromage, H., Tempst, P., & Nathan, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406133102 · Cited by 167
Self-citationKorf, H., Beken, S. V., Romano, M., Steffensen, K. R., Stijlemans, B., Gustafsson, J.-�., Grooten, J., & Huygen, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35288 · Cited by 165
Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier
Rhee, K. Y., de Carvalho, L. P. S., Bryk, R., Ehrt, S., Marrero, J., Park, S. W., Schnappinger, D., Venugopal, A., & Nathan, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.03.008 · Cited by 166
Self-citationFresh Approaches to Anti-Infective Therapies
Nathan, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003081 · Cited by 167
Self-citationKendall, S. L., Burgess, P., Balhana, R., Withers, M., ten Bokum, A., Lott, J. S., Gao, C., Uhía, I., & Stoker, N. G. (2010) · Microbiology · doi:10.1099/mic.0.034538-0 · Cited by 163
Saini, V., Cumming, B. M., Guidry, L., Lamprecht, D. A., Adamson, J., Reddy, V. P., Chinta, K. C., Mazorodze, J. H., Glasgow, J. N., Richard‐Greenblatt, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.056 · Cited by 160
Modification of iron regulation by the inflammatory response
WEISS, G. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.001 · Cited by 161
Catabolism and biotechnological applications of cholesterol degrading bacteria
García, J. L., Uhía, I., & Galán, B. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2012.00331.x · Cited by 161
Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis
Hasan, S., Daugelat, S., Rao, P. S. S., & Schreiber, M. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020061 · Cited by 157
Biosynthesis and Recycling of Nicotinamide Cofactors in Mycobacterium tuberculosis
Boshoff, H. I., Xu, X., Tahlan, K., Dowd, C. S., Pethe, K., Camacho, L. R., Park, T.-H., Yun, C., Schnappinger, D., Ehrt, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800694200 · Cited by 160
Self-citationGouzy, A., Larrouy-Maumus, G. J., Bottai, D., Levillain, F., Dumas, A., Wallach, J. B., Brandli, I., de Chastellier, C., Wu, T., Poincloux, R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003928 · Cited by 165
Self-citationRoupie, V., Romano, M., Zhang, L., Korf, H., Lin, M. Y., Franken, K. L. M. C., Ottenhoff, T. H. M., Klein, M. R., & Huygen, K. (2006) · Infection and Immunity · doi:10.1128/iai.01137-06 · Cited by 158
Sirakova, T. D., Dubey, V. S., Deb, C., Daniel, J., Korotkova, T. A., Abomoelak, B., & Kolattukudy, P. E. (2006) · Microbiology · doi:10.1099/mic.0.28993-0 · Cited by 158
Black, G. F., Thiel, B., Ota, M. O. C., Parida, S. K., Adegbola, R. A., Boom, W. H., Dockrell, H. M., Franken, K. L. M. C., Friggen, A. H., Hill, P. C., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00111-09 · Cited by 156
Self-citationRUTI: A new chance to shorten the treatment of latent tuberculosis infection
Cardona, P.-J. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.024 · Cited by 159
Molecular basis of mycobacterial survival in macrophages
Awuh, J. A., & Flo, T. H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2422-8 · Cited by 160
Systems biology of persistent infection: tuberculosis as a case study
Young, D. B., Stark, J., & Kirschner, D. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1919 · Cited by 155
Converse, P. J., Karakousis, P. C., Klinkenberg, L. G., Kesavan, A. K., Ly, L. H., Allen, S. S., Grosset, J. H. E., Jain, S. K., Lamichhane, G., Manabe, Y. C., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01117-08 · Cited by 152
Pathogen roid rage: Cholesterol utilization byMycobacterium tuberculosis
Wipperman, M. F., Sampson, N. S., & Thomas, S. T. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.895700 · Cited by 152
Nutritional Risk Factors for Tuberculosis Among Adults in the United States, 1971–1992
Cegielski, J. P., Arab, L., & Cornoni‐Huntley, J. C. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws007 · Cited by 152
PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism
Kim, Y. S., Lee, H. M., Kim, J. K., Yang, C., Kim, T. S., Jung, M., Jin, H. S., Kim, S., Jang, J., Oh, G. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601920 · Cited by 151
igr Genes and Mycobacterium tuberculosis Cholesterol Metabolism
Chang, J. C., Miner, M. D., Pandey, A. K., Gill, W., Harik, N., Sassetti, C. M., & Sherman, D. R. (2009) · Journal of Bacteriology · doi:10.1128/jb.00452-09 · Cited by 150
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
Chikhale, R. V., Barmade, M. A., Murumkar, P. R., & Yadav, M. R. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00281 · Cited by 151
Jain, S. K., Satyaseela, M. P., Lamichhane, G., Kim, K. S., & Bishai, W. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/502631 · Cited by 148
Mycobacterial Dormancy Systems and Host Responses in Tuberculosis
Peddireddy, V., Doddam, S. N., & Ahmed, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00084 · Cited by 157
Nutrient acquisition by mycobacteria
Niederweis, M. (2008) · Microbiology · doi:10.1099/mic.0.2007/012872-0 · Cited by 144
Multiple chaperonins in bacteria – why so many?
Lund, P. A. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00178.x · Cited by 147
Singh, R., Barry, C. E., & Boshoff, H. I. (2010) · Journal of Bacteriology · doi:10.1128/jb.01285-09 · Cited by 148
Hu, Y., Movahedzadeh, F., Stoker, N. G., & Coates, A. R. M. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.861-868.2006 · Cited by 147
Keating, L. A., Wheeler, P. R., Mansoor, H., Inwald, J. K., Dale, J., Hewinson, R. G., & Gordon, S. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04524.x · Cited by 145
Macrophage nutriprive antimicrobial mechanisms
Appelberg, R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206079 · Cited by 152
Identification of gene targets against dormant phase Mycobacterium tuberculosis infections
Murphy, D. J., & Brown, J. R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-84 · Cited by 147
Upton, A. M., & McKinney, J. D. (2007) · Microbiology · doi:10.1099/mic.0.2007/011726-0 · Cited by 151
DosT and DevS are oxygen‐switched kinases in Mycobacterium tuberculosis
Sousa, E. H. S., Tuckerman, J. R., Gonzalez, G., & Gilles‐Gonzalez, M. (2007) · Protein Science · doi:10.1110/ps.072897707 · Cited by 145
Bacterial Genomics and Pathogen Evolution
Raskin, D. M., Seshadri, R., Pukatzki, S. U., & Mekalanos, J. J. (2006) · Cell · doi:10.1016/j.cell.2006.02.002 · Cited by 142
Tuberculosis vaccines: Time to think about the next generation
Kaufmann, S. H. E. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.006 · Cited by 145
Regulation of the Mycobacterium tuberculosis PE/PPE genes
Voskuil, M. I., Schnappinger, D., Rutherford, R. S., Liu, Y., & Schoolnik, G. K. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.12.014 · Cited by 139
Self-citationVenugopal, A., Bryk, R., Shi, S., Rhee, K. Y., Rath, P., Schnappinger, D., Ehrt, S., & Nathan, C. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2010.12.004 · Cited by 139
Self-citationBeites, T., O’Brien, K. M., Tiwari, D., Engelhart, C. A., Walters, S. B., Andrews, J., Yang, H., Sutphen, M. L., Weiner, D. M., Dayao, E. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12956-2 · Cited by 143
Self-citationBacterial sRNAs: Regulation in stress
Hoe, C. H., Raabe, C. A., Rozhdestvensky, T. S., & Tang, T. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.04.002 · Cited by 144
Bacon, J., James, B. W., Wernisch, L., Williams, A., Morley, K. A., Hatch, G. J., Mangan, J. A., Hinds, J., Stoker, N. G., Butcher, P. D., et al. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.12.011 · Cited by 137
Self-citationDrug Targets in Mycobacterial Sulfur Metabolism
Bhave, D. P., Muse, W. B., & Carroll, K. S. (2007) · Infectious Disorders - Drug Targets · doi:10.2174/187152607781001772 · Cited by 139
Viljoen, A. J., Dubois, V., Girard‐Misguich, F., Blaise, M., Herrmann, J., & Kremer, L. (2017) · Molecular Microbiology · doi:10.1111/mmi.13675 · Cited by 137
Warner, D. F., & Mizrahi, V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-05 · Cited by 135
Carbon flux rerouting during Mycobacterium tuberculosis growth arrest
Shi, L., Sohaskey, C. D., Pheiffer, C., Datta, P., Parks, M., McFadden, J., North, R. J., & Gennaro, M. L. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07399.x · Cited by 139
Hartkoorn, R. C., Chandler, B., Owen, A., Ward, S. A., Squire, S. B., Back, D. J., & Khoo, S. (2007) · Tuberculosis · doi:10.1016/j.tube.2006.12.001 · Cited by 131
Drumm, J. E., Mi, K., Bilder, P. W., Sun, M., Lim, J., Bielefeldt‐Ohmann, H., Basaraba, R. J., So, M., Zhu, G., Tufariello, J. M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000460 · Cited by 135
The Global Responses of Mycobacterium tuberculosis to Physiological Levels of Copper
Ward, S. K., Hoye, E. A., & Talaat, A. M. (2008) · Journal of Bacteriology · doi:10.1128/jb.01847-07 · Cited by 131
Sritharan, M. (2016) · Journal of Bacteriology · doi:10.1128/jb.00359-16 · Cited by 138
Jung, Y., Ryan, L., LaCourse, R., & North, R. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050265 · Cited by 133
Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings
Chauhan, A., Madiraju, M. V. V. S., Fol, M., Lofton, H., Maloney, E., Reynolds, R., & Rajagopalan, M. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.5.1856-1865.2006 · Cited by 132
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Gold, B. S., & Nathan, C. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0031-2016 · Cited by 134
Self-citationCaseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters
Sarathy, J. P., & Dartois, V. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00159-19 · Cited by 138
Ouellet, H., Guan, S., Johnston, J. B., Chow, E. D., Kells, P. M., Burlingame, A. L., Cox, J. S., Podust, L. M., & de Montellano, P. R. O. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07243.x · Cited by 133
Zvi, A., Ariel, N., Fulkerson, J., SADOFF, J. C., & Avigdor Shafferman, C. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-18 · Cited by 129
Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria
Richardson, A. R., Somerville, G. A., & Sonenshein, A. L. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0004-2014 · Cited by 138
Cook, G. M., Hards, K., Dunn, E. A., Heikal, A., Nakatani, Y., Greening, C., Crick, D. C., Fontes, F. L., Pethe, K., Hasenoehrl, E., et al. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0014-2016 · Cited by 131
Shleeva, M. O., Kudykina, Y. K., Vostroknutova, G. N., Сузина, Н. Е., Mulyukin, A. L., & Kaprelyants, A. S. (2011) · Tuberculosis · doi:10.1016/j.tube.2010.12.006 · Cited by 132
Global transcriptional response to vancomycin in Mycobacterium tuberculosis
Provvedi, R., Boldrin, F., Falciani, F., Palù, G., & Manganelli, R. (2009) · Microbiology · doi:10.1099/mic.0.024802-0 · Cited by 132
Metadata
- Authors
- Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., & Schoolnik, G. K.
- Affiliations
- Cornell University (US)
- 3Department of Microbiology and Immunology, Weill Medical College and Graduate Programs in
- Stanford Medicine (US)
- St George's, University of London (GB)
- University of California, San Francisco (US)
- Stanford University (US)
- Corresponding author
- Schnappinger, Dirk
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-09-01
- Volume
- 198
- Issue
- 5
- Pages
- 693-704
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194186
- OpenAlex
- W2007097682
- Cited by
- 1,420
- References
- 58
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 46 · 2023: 32 · 2022: 55 · 2021: 41 · 2020: 37 · 2019: 68 · 2018: 63 · 2017: 65 · 2016: 61 · 2015: 96 · 2014: 90 · 2013: 75 · 2012: 96
- FWCI
- 31.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Funders
- Hearst Foundations
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Defense Advanced Research Projects Agency
- Advanced Research Projects Agency
- Medical Research Council
- National Heart, Lung, and Blood Institute (R01HL068525, HL 61241, HL68525, R01HL061241)
- National Institute of Allergy and Infectious Diseases (R01AI044826, AI-44826)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Mycobacterium tuberculosis, macrophages, nitric oxide synthase 2, interferon-gamma, iron scavenging, anaerobic respiration, fatty acid beta-oxidation, sigma E, cell envelope damage, hypoxia, nitrosative stress, tuberculosis pathogenesis
- MeSH terms
- Animals, Macrophages, Mycobacterium tuberculosis, Phagosomes, RNA, Bacterial, Transcription, Genetic, Gene Expression Regulation, Bacterial, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
